CA1111021A - Derives de l'acyle - Google Patents

Derives de l'acyle

Info

Publication number
CA1111021A
CA1111021A CA229,803A CA229803A CA1111021A CA 1111021 A CA1111021 A CA 1111021A CA 229803 A CA229803 A CA 229803A CA 1111021 A CA1111021 A CA 1111021A
Authority
CA
Canada
Prior art keywords
formula
methyl
dioxo
tetrahydro
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA229,803A
Other languages
English (en)
Other versions
CA229803S (en
Inventor
Marc Montavon
Roland Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to CA000387618A priority Critical patent/CA1240314A/fr
Application granted granted Critical
Publication of CA1111021A publication Critical patent/CA1111021A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA229,803A 1974-06-21 1975-06-20 Derives de l'acyle Expired CA1111021A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000387618A CA1240314A (fr) 1974-06-21 1981-10-08 Derives acyl

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH8537/74 1974-06-21
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (1)

Publication Number Publication Date
CA1111021A true CA1111021A (fr) 1981-10-20

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
CA229,803A Expired CA1111021A (fr) 1974-06-21 1975-06-20 Derives de l'acyle

Country Status (25)

Country Link
JP (1) JPS625917B2 (fr)
AT (1) AT337897B (fr)
AU (1) AU498387B2 (fr)
BE (1) BE830455A (fr)
BR (1) BR7503782A (fr)
CA (1) CA1111021A (fr)
CH (1) CH609989A5 (fr)
CU (1) CU34293A (fr)
DD (1) DD121113A5 (fr)
DE (1) DE2527291A1 (fr)
DK (2) DK153155C (fr)
FI (1) FI751815A7 (fr)
FR (1) FR2275215A1 (fr)
GB (1) GB1471804A (fr)
HU (1) HU170576B (fr)
IE (1) IE41888B1 (fr)
IL (1) IL47299A (fr)
LU (1) LU72771A1 (fr)
NL (1) NL180665C (fr)
NO (1) NO752202L (fr)
NZ (1) NZ177508A (fr)
PH (1) PH13030A (fr)
SE (1) SE431755B (fr)
SU (2) SU635873A3 (fr)
ZA (1) ZA753086B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
WO2002085914A2 (fr) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Procede permettant de preparer des derives d'acide 3-cephalosporanique a l'aide de derives d'acide cetonique alpha
PT2250156E (pt) 2008-03-05 2015-09-09 Merck Patent Gmbh Derivados de pirazinona como estimuladores da secreção de insulina, métodos para a sua obtenção e utilização destes para o tratamento de diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
CH609989A5 (en) 1979-03-30
DE2527291C2 (fr) 1988-01-14
DK153155C (da) 1988-10-31
DD121113A5 (fr) 1976-07-12
FR2275215B1 (fr) 1980-05-16
IL47299A (en) 1979-01-31
NZ177508A (en) 1978-04-03
IL47299A0 (en) 1976-10-31
DK271975A (da) 1975-12-22
DK453687A (da) 1987-08-28
DK155329C (da) 1989-08-07
BE830455A (fr) 1975-12-22
SE7506908L (sv) 1975-12-22
BR7503782A (pt) 1976-07-06
IE41888B1 (en) 1980-04-23
SU635873A3 (ru) 1978-11-30
HU170576B (fr) 1977-07-28
ATA476975A (de) 1976-11-15
JPS5113793A (fr) 1976-02-03
NL180665B (nl) 1986-11-03
LU72771A1 (fr) 1977-03-04
NL7507390A (nl) 1975-12-23
DK155329B (da) 1989-03-28
FI751815A7 (fr) 1975-12-22
PH13030A (en) 1979-11-15
AU8191275A (en) 1976-12-09
GB1471804A (en) 1977-04-27
SU589921A3 (ru) 1978-01-25
DE2527291A1 (de) 1976-01-08
CU34293A (es) 1979-01-16
SE431755B (sv) 1984-02-27
NL180665C (nl) 1987-04-01
DK153155B (da) 1988-06-20
IE41888L (en) 1975-12-21
DK453687D0 (da) 1987-08-28
FR2275215A1 (fr) 1976-01-16
NO752202L (fr) 1975-12-23
JPS625917B2 (fr) 1987-02-07
AU498387B2 (en) 1979-03-08
AT337897B (de) 1977-07-25
ZA753086B (en) 1976-04-28

Similar Documents

Publication Publication Date Title
US4470983A (en) Cephalosporin derivatives
EP0189287B1 (fr) Bêta-lactames antibiotiques
CA1103237A (fr) Procede d'obtention de derives insatures d'acides 7- acylamido-3-cephem-4-carboxyliques
US5223619A (en) Process for the preparation of 9-substituted guanine derivatives
GB2099418A (en) Cephalosporin derivatives
CA1146542A (fr) Lactames, leur preparation, et produits pharmaceutiques qui les renferment
US4144391A (en) Cephalosporin displacement reaction
EP0158494B1 (fr) Dérivés de péname et procédé pour leur préparation
US4091211A (en) Cephalosporins
Numata et al. A NEW CEPHALOSPORIN. SCE-963: 7-[2-(2-AMINOTHIAZOL-4-YL)-ACETAMIDO]-3-[[[1-(2-DIMETHYLAMINOETHYL)-1H-TETRAZOL-5-YL]-THIO] METHYL] CEPH-3-EM-4-CARBOXYLIC ACID CHEMISTRY AND STRUCTURE-ACTIVITY RELATIONSHIPS
IE41888B1 (en) Substituted desacetoxy-7-acylamino-cephalosporanic acids
US3449338A (en) Cephalosporin ca derivatives
IE41590B1 (en) Novel cephalosporin compounds
US4348518A (en) Cephalosporins
CA1114808A (fr) Derives d'oxyiminoacetamidocephalosporines substituees en 7
CA1240314A (fr) Derives acyl
US4117125A (en) 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
EP0045717B1 (fr) Dérivés de céphalosporine, leur préparation et leur application
KR790001023B1 (ko) 아실 유도체의 제조방법
US4117124A (en) 7-Acylamino-3-[[3-(carboxymethyl)thio-1H-1,2,4-triazol-5-yl]thiomethyl]-3-cephem-4-carboxylic acids
US4117123A (en) 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
US4178443A (en) Derivatives of 7 [-substituted oxyimins acetamido] cephalosporins
US4520195A (en) 5-Oxo-as-triazines
US4174323A (en) 1-(2-Sulfamidoethyl)-1,4-dihydro-5H-tetrazole-5-thione
US3904616A (en) Cephalosporins

Legal Events

Date Code Title Description
MKEX Expiry